Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study
Guloksuz, S., Pries, L.K., Delespaul, P., Kenis, G., Luykx, J.J., Lin, B.D.,
De Haan, L., GROUP Researchers & van Os, J.
Verschenen in World Psychiatry, 18(2), 173-182 (2019)
Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning – Results from the EU-GEI study
Menghini-Müller, S., Studerus, E., Ittig, S., Heitz, U., Egloff, L., Andreou, C., Valmaggia, L.R., Kempton, M.J., van der Gaag, M.,
De Haan, L. & et al.
Verschenen in European Psychiatry, 59, 52-59 (2019)
Plasma dopa decarboxylase activity in treatment-resistant recent-onset psychosis patients
van der Pluijm, M., Sutterland, A.L., van Kullenbrog, A.B.P., Zoetekouw, L.,
De Haan, L., Booij, J. & van de Giessen, E.
Verschenen in Therapeutic Advances in Psychopharmacology, 9, 1-7 (2019)
Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use
Ferraro, L., La Cascia, C., Quattrone, D., Sideli, L., Matranga, D., Cappucio, V., WP2 EU-GEI Group,
De Haan, L. & di Forti, M., et al.
Verschenen in Schizophrenia Bulletin, Volume 46, Issue 3, 517–529 (2019)
Use of Natural Language Processing to identify Obsessive Compulsive Symptoms in patients with schizophrenia, schizoaffective disorder or bipolar disorder
Chandran, D., Robbins, D.A., Chang, C.K., Shetty, H., Sanyal, J., Downs, J., Fok, M., Ball, M., Jackson, R., Stewart, R., Cohen, R., Vermeulen, J.M.,
Schirmbeck, F.,
De Haan, L. & Hayes, R.
Verschenen in Scientific Reports, 9, 14146, 1-7 (2019)
Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years
Vermeulen, J.M., van Rooijen, G., van de Kerkhof, M.P.J., Sutterland, A.L., Correll, C.U. &
De Haan, L.Verschenen in Schizophrenia Bulletin, Volume 45, Issue 2, 315-329 (2019)
Effectiveness of Integrated Dual Diagnosis Treatment (IDDT) in severe mental illness outpatients with a co-occurring substance use disorder
Kikkert, M.J.,
Goudriaan, A.E.,
De Waal, M.M.,
Peen, J. &
Dekker, J.J.M.Verschenen in Journal of Substance Abuse Treatment, 95, 35-42 (2018)
Exploring construct validity of clinical staging in schizophrenia spectrum disorders in an acute psychiatric ward
Berendsen, S., van der Paardt, J., van Bruggen, M., Nusselder, H., Jalink, M.,
Peen, J.,
Van, H.,
Dekker, J.J.M. &
De Haan, L.Verschenen in Clinical Schizophrenia & Related Psychoses (2018)
Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study
Swets, M., van Dijk, F.A.,
Schirmbeck, F.,
Peen, J.,
De Haan, L., Alizadeh, B.Z. & van Winkel, R.
Verschenen in Psychiatry Research, 271, 421-427 (2018)
The impact of affective symptoms on personal recovery of patients with severe mental illness
Van Eck, R.,
Burger, T., Schenkelaars, M.,
Vellinga, A.,
De Koning, M.B.,
Schirmbeck, F.,
Kikkert, M.J.,
Dekker, J.J.M. &
De Haan, L.Verschenen in International Journal of Social Psychiatry , Vol. 64 (6), 521-527 (2018)
Genetic Risk and Outcome of Psychosis (GROUP) investigators. Association Between Smoking Behavior and Cognitive Functioning in Patients With Psychosis, Siblings, and Healthy Control Subjects: Results From a Prospective 6-Year Follow-Up Study
Vermeulen, J.M.,
Schirmbeck, F.,
Blankers, M., van Tricht, M.J., Bruggeman, R., van den Brink, W.,
De Haan, L. & GROUP Investigators
Verschenen in American Journal of Psychiatry, 175 (11), 1121-1128 (2018)
The relationship between clinical and personal recovery in patients with schizophrenia spectrum disorders: a systematic review and meta-analysis
Van Eck, R.,
Burger, T.,
Vellinga, A.,
Schirmbeck, F. &
De Haan, L.Verschenen in Schizophrenia Bulletin, 44 (3), 631-642 (2018)
Validity of police contacts as a performance indicator for the public mental health care system in Amsterdam: an open cohort study
Lauriks, S., Buster, M.C.A., de Wit, M.A.S., Arah, O.A., Hoogendoorn, A.W.,
Peen, J. & Klazinga, N.S.
Verschenen in Social Psychiatry and Psychiatric Epidemiology, 53, 577–586 (2018)
Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk
Hagen, J.M., Sutterland, A.L., Koeter, M.W.J., Lutter, R., Cohn, D.M. &
De Haan, L.Verschenen in The Journal of Clinical Psychiatry (2017)
Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome
Bakker, G., Caan, M.W.A., Vingerhoets, W.A.M., da Silva-Alves, F.,
De Koning, M.B., Boot, E., Nieman, D.H.,
De Haan, L., Bloemen, O.J., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in PlosOne (2016)
Establishing reference values for age-related spermatogonial quantity in prepubertal human testes: a systematic review and meta-analysis
Masliukaite, I.,
Hagen, J.M., Jahnukainen, K., van der Veen, F., van Wely, M. & van Pelt, A.M.M.
Verschenen in Fertility and Sterility, 106 (7), 1652-1657 (2016)
The association between ethnic background and characteristics of first mental health treatment for psychotic disorders in the Netherlands between 2001 and 2005
Fassaert, T., Heijnen, H., de Wit, M.A.S.,
Peen, J.,
Beekman, A.T.F. &
Dekker, J.J.M.Verschenen in Social Psychiatry and Psychiatric Epidemiology, 51, 1591–1601 (2016)
Pathways through care of severely mentally ill individuals experiencing multiple public crisis events: a qualitative description
Hensen, M.J.,
De Mooij, L.D., Theunissen, J.,
Dekker, J.J.M., Willemsen, M.,
Zoeteman, J.,
Peen, J. & de Wit, M.A.S.
Verschenen in BMC Psychiatry, 16, 84 (2016)
